Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $17.28 billion. The enterprise value is $16.59 billion.

Market Cap	17.28B
Enterprise Value	16.59B

Important Dates

The next estimated earnings date is Monday, May 4, 2026, after market close.

Earnings Date	May 4, 2026
Ex-Dividend Date	n/a

Share Statistics

SMMT has 776.08 million shares outstanding. The number of shares has increased by 4.06% in one year.

Current Share Class	776.08M
Shares Outstanding	776.08M
Shares Change (YoY)	+4.06%
Shares Change (QoQ)	+3.09%
Owned by Insiders (%)	78.52%
Owned by Institutions (%)	15.27%
Float	134.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	3,532.29
PB Ratio	26.21
P/TBV Ratio	26.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.87, with a Debt / Equity ratio of 0.03.

Current Ratio	9.87
Quick Ratio	9.77
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -206.10% and return on invested capital (ROIC) is -127.17%.

Return on Equity (ROE)	-206.10%
Return on Assets (ROA)	-115.28%
Return on Invested Capital (ROIC)	-127.17%
Return on Capital Employed (ROCE)	-161.37%
Weighted Average Cost of Capital (WACC)	-3.26%
Revenue Per Employee	n/a
Profits Per Employee	-$4.07M
Employee Count	265
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.57% in the last 52 weeks. The beta is -1.37, so SMMT's price volatility has been lower than the market average.

Beta (5Y)	-1.37
52-Week Price Change	-18.57%
50-Day Moving Average	17.73
200-Day Moving Average	19.86
Relative Strength Index (RSI)	57.85
Average Volume (20 Days)	3,734,034

Short Selling Information

The latest short interest is 34.56 million, so 23.14% of the outstanding shares have been sold short.

Short Interest	34.56M
Short Previous Month	36.12M
Short % of Shares Out	23.14%
Short % of Float	n/a
Short Ratio (days to cover)	13.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.09B
Pretax Income	-1.08B
Net Income	-1.08B
EBITDA	-1.09B
EBIT	-1.09B
Earnings Per Share (EPS)	-$1.44

Balance Sheet

The company has $713.45 million in cash and $20.89 million in debt, with a net cash position of $692.56 million or $0.89 per share.

Cash & Cash Equivalents	713.45M
Total Debt	20.89M
Net Cash	692.56M
Net Cash Per Share	$0.89
Equity (Book Value)	658.86M
Book Value Per Share	0.85
Working Capital	647.31M

Cash Flow

In the last 12 months, operating cash flow was -$322.93 million and capital expenditures -$657,000, giving a free cash flow of -$323.59 million.

Operating Cash Flow	-322.93M
Capital Expenditures	-657,000
Depreciation & Amortization	146,000
Net Borrowing	n/a
Free Cash Flow	-323.59M
FCF Per Share	-$0.42

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.06%
Shareholder Yield	-4.06%
Earnings Yield	-6.25%
FCF Yield	-1.87%

Analyst Forecast

The average price target for SMMT is $32.93, which is 47.87% higher than the current price. The consensus rating is "Buy".

Price Target	$32.93
Price Target Difference	47.87%
Analyst Consensus	Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1